About Us

Azothis is a MedTech company created with the aim of finding radically new solutions to the most complex diseases that plagues mankind. The company comprises of a Scientific Committee and an Engineering Team led by a seasoned management team. Azothis has been upfront focusing on system’s development and clinical research. Azothis strategy relies upon the need for developing new therapy approaches in indications such as cardiovascular diseases and deep venous thrombosis (DVT) as well as for metabolic disorders such as diabetes, which are not fully satisfactory at the present time.  With this in mind, Azothis was able to design a brand new technology called Endothelial Therapy® (ET®). The revolutionary new ET® has been supported as well by scientific findings independent of Azothis that have been published in several journals and publications confirming Azothis’ claims and findings upon ET®. In conjunction with the scientific committee, Azothis’ engineering team has managed to design and build a functional device that successfully makes use of ETs®.